日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

用于评估体内结核病免疫力的卡介苗人体感染模型开发的1期开放标签剂量递增试验

Blazevic, Azra; Edwards, Rachel L; Xia, Mei; Eickhoff, Christopher S; Hamzabegovic, Fahreta; Meza, Krystal A; Ning, Huan; Tennant, Janice; Mosby, Karla J; Ritchie, James C; Girmay, Tigisty; Lai, Lilin; McCullough, Michele; Beck, Allison; Kelley, Colleen; Edupuganti, Srilatha; Kabbani, Sarah; Buchanan, Wendy; Makhene, Mamodikoe K; Voronca, Delia; Cherikh, Sami; Goll, Johannes B; Rouphael, Nadine G; Mulligan, Mark J; Hoft, Daniel F

Adverse Reactions and Complication in Voluntary Blood Donors

自愿献血者的不良反应和并发症

Smajic, Sabina Camdzic; Becarevic, Munevera; Klapic, Samra; Seletovic, Fahreta; Sahovic, Alisa

BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity

卡介苗接种可诱导鸟分枝杆菌和脓肿分枝杆菌的交叉保护性免疫

Abate, Getahun; Hamzabegovic, Fahreta; Eickhoff, Christopher S; Hoft, Daniel F

Mycobacterium-Specific γ9δ2 T Cells Mediate Both Pathogen-Inhibitory and CD40 Ligand-Dependent Antigen Presentation Effects Important for Tuberculosis Immunity

分枝杆菌特异性γ9δ2 T细胞介导病原体抑制和CD40配体依赖性抗原呈递效应,这对结核病免疫至关重要。

Abate, Getahun; Spencer, Charles T; Hamzabegovic, Fahreta; Blazevic, Azra; Xia, Mei; Hoft, Daniel F

New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells

新型维拉帕米类似物抑制细胞内分枝杆菌,而不影响分枝杆菌特异性T细胞的功能

Abate, Getahun; Ruminiski, Peter G; Kumar, Malkeet; Singh, Kawaljit; Hamzabegovic, Fahreta; Hoft, Daniel F; Eickhoff, Christopher S; Selimovic, Asmir; Campbell, Mary; Chibale, Kelly